Outcome of SARS-CoV-2 infection is linked to MAIT cell activation and cytotoxicity

[1]  Y. Hu,et al.  [Asymptomatic infection of COVID-19 and its challenge to epidemic prevention and control]. , 2020, Zhonghua liu xing bing xue za zhi = Zhonghua liuxingbingxue zazhi.

[2]  M. Si-Tahar,et al.  Phenotypical and functional alteration of unconventional T cells in severe COVID-19 patients , 2020, The Journal of experimental medicine.

[3]  H. Ljunggren,et al.  MAIT cell activation and dynamics associated with COVID-19 disease severity , 2020, Science Immunology.

[4]  Madeleine K. D. Scott,et al.  Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans , 2020, Science.

[5]  J. McCluskey,et al.  Mucosal-associated invariant T cells promote inflammation and intestinal dysbiosis leading to metabolic dysfunction during obesity , 2020, Nature Communications.

[6]  Roland Eils,et al.  COVID-19 severity correlates with airway epithelium–immune cell interactions identified by single-cell analysis , 2020, Nature Biotechnology.

[7]  Sihua Wang,et al.  The lung tissue microbiota features of 20 deceased patients with COVID-19 , 2020, Journal of Infection.

[8]  S. Hadjadj,et al.  Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study , 2020, Diabetologia.

[9]  M. Merad,et al.  Pathological inflammation in patients with COVID-19: a key role for monocytes and macrophages , 2020, Nature Reviews Immunology.

[10]  Benjamin J. Polacco,et al.  A SARS-CoV-2 Protein Interaction Map Reveals Targets for Drug-Repurposing , 2020, Nature.

[11]  Zhiyong Ma,et al.  Characteristics of Peripheral Lymphocyte Subset Alteration in COVID-19 Pneumonia , 2020, The Journal of infectious diseases.

[12]  Xiaohu Zheng,et al.  Pathogenic T-cells and inflammatory monocytes incite inflammatory storms in severe COVID-19 patients , 2020, National science review.

[13]  A. M. Leontovich,et al.  The species Severe acute respiratory syndrome-related coronavirus: classifying 2019-nCoV and naming it SARS-CoV-2 , 2020, Nature Microbiology.

[14]  J. Xiang,et al.  Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study , 2020, The Lancet.

[15]  B. Graham,et al.  Cryo-EM structure of the 2019-nCoV spike in the prefusion conformation , 2020, Science.

[16]  Ting Yu,et al.  Epidemiological and clinical characteristics of 99 cases of 2019 novel coronavirus pneumonia in Wuhan, China: a descriptive study , 2020, The Lancet.

[17]  Jonathan L. Linehan,et al.  MAIT cells are imprinted by the microbiota in early life and promote tissue repair , 2019, Science.

[18]  S. Lotersztajn,et al.  Mucosal-associated invariant T cells and disease , 2019, Nature Reviews Immunology.

[19]  P. Klenerman,et al.  TCR and Inflammatory Signals Tune Human MAIT Cells to Exert Specific Tissue Repair and Effector Functions , 2018, bioRxiv.

[20]  Daniela C Hernández,et al.  Innate lymphoid cells in lung infection and immunity , 2018, Immunological reviews.

[21]  E. Remmerswaal,et al.  Blimp‐1 induces and Hobit maintains the cytotoxic mediator granzyme B in CD8 T cells , 2018, European journal of immunology.

[22]  V. Paradis,et al.  Mucosal-associated invariant T cells are a profibrogenic immune cell population in the liver , 2018, Nature Communications.

[23]  P. Klenerman,et al.  MAIT cells and viruses , 2018, Immunology and cell biology.

[24]  R. Scharfmann,et al.  Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes , 2017, Nature Immunology.

[25]  Stéphane Le Crom,et al.  Aozan: an automated post‐sequencing data‐processing pipeline , 2017, Bioinform..

[26]  L. Loh,et al.  Human mucosal-associated invariant T cells contribute to antiviral influenza immunity via IL-18–dependent activation , 2016, Proceedings of the National Academy of Sciences.

[27]  Edward C Hutchinson,et al.  MAIT cells are activated during human viral infections , 2016, Nature Communications.

[28]  A. Sönnerborg,et al.  Arming of MAIT Cell Cytolytic Antimicrobial Activity Is Induced by IL-7 and Defective in HIV-1 Infection , 2015, PLoS pathogens.

[29]  K. Clément,et al.  Mucosal-associated invariant T cell alterations in obese and type 2 diabetic patients. , 2015, The Journal of clinical investigation.

[30]  P. Klenerman,et al.  MAIT cells are licensed through granzyme exchange to kill bacterially sensitized targets , 2014, Mucosal Immunology.

[31]  D. Sinderen,et al.  T-cell activation by transitory neo-antigens derived from distinct microbial pathways , 2014, Nature.

[32]  J. Chiche,et al.  Specific MAIT cell behaviour among innate-like T lymphocytes in critically ill patients with severe infections , 2014, Intensive Care Medicine.

[33]  C. Willberg,et al.  CD161++CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner , 2013, European journal of immunology.

[34]  A. Sönnerborg,et al.  Activation, exhaustion, and persistent decline of the antimicrobial MR1-restricted MAIT-cell population in chronic HIV-1 infection. , 2013, Blood.

[35]  A. Brass,et al.  Distinct Patterns of IFITM-Mediated Restriction of Filoviruses, SARS Coronavirus, and Influenza A Virus , 2011, PLoS pathogens.

[36]  J. Schlesinger,et al.  Primary Human Splenic Macrophages, but Not T or B Cells, Are the Principal Target Cells for Dengue Virus Infection In Vitro , 2007, Journal of Virology.

[37]  Seyed E. Hasnain,et al.  Host-pathogen interactions during apoptosis , 2003, Journal of Biosciences.

[38]  Olivier Lantz,et al.  Selection of evolutionarily conserved mucosal-associated invariant T cells by MR1 , 2003, Nature.

[39]  W. Rozenbaum,et al.  Quantification of Human Immunodeficiency Virus Type 1 Proviral Load by a TaqMan Real-Time PCR Assay , 2001, Journal of Clinical Microbiology.

[40]  A. Alcamí,et al.  Vaccinia virus encodes a soluble type I interferon receptor of novel structure and broad species soecificity , 1995, Cell.

[41]  R. Chambers,et al.  Acute Respiratory Distress Syndrome , 2017, The New England journal of medicine.

[42]  Malgorzata Nowicka,et al.  CyTOF workflow: differential discovery in high-throughput high-dimensional cytometry datasets. , 2017, F1000Research.